{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:14:28Z","timestamp":1781187268528,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12015-020-09954-z","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T22:02:27Z","timestamp":1579212147000},"page":"276-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Therapeutic Potential of Mesenchymal Stromal Stem Cells in Rheumatoid Arthritis: a Systematic Review of In Vivo Studies"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-7251","authenticated-orcid":false,"given":"Alexia","family":"Karamini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Bakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2823-690X","authenticated-orcid":false,"given":"Dimitrios","family":"Andreadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6407-8494","authenticated-orcid":false,"given":"Konstantinos","family":"Gkiouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2067-8842","authenticated-orcid":false,"given":"Aristeidis","family":"Kritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"key":"9954_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cellimm.2017.01.008","volume":"314","author":"P Usha Shalini","year":"2017","unstructured":"Usha Shalini, P., Vidyasagar, J. V. S., Kona, L. K., Ponnana, M., & Chelluri, L. K. (2017). In vitro allogeneic immune cell response to mesenchymal stromal cells derived from human adipose in patients with rheumatoid arthritis. Cellular Immunology, 314, 18\u201325. https:\/\/doi.org\/10.1016\/j.cellimm.2017.01.008.","journal-title":"Cellular Immunology"},{"key":"9954_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1541-4","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang, Y., He, X., Zhao, R., Guo, W., Zhu, M., Xing, W., Jiang, D., & Liu, C. (2018). Serum IFN - \u03b3 levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. Journal of Translational Medicine, 16, 1\u20139. https:\/\/doi.org\/10.1186\/s12967-018-1541-4.","journal-title":"Journal of Translational Medicine"},{"issue":"6","key":"9954_CR3","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.30309","volume":"63","author":"K Oshita","year":"2011","unstructured":"Oshita, K., Yamaoka, K., Udagawa, N., Fukuyo, S., Sonomoto, K., Maeshima, K., Kurihara, R., Nakano, K., Saito, K., Okada, Y., Chiba, K., & Tanaka, Y. (2011). Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis and Rheumatism, 63(6), 1658\u20131667. https:\/\/doi.org\/10.1002\/art.30309.","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"9954_CR4","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3892\/mmr.2016.5721","volume":"14","author":"J Zeng","year":"2016","unstructured":"Zeng, J., Wang, F., & Mao, M. (2016). Co-culture of fibroblast-like synoviocytes with umbilical cord-mesenchymal stem cells inhibits expression of pro-inflammatory proteins, induces apoptosis and promotes chondrogenesis. Molecular Medicine Reports, 14(4), 3887\u20133893. https:\/\/doi.org\/10.3892\/mmr.2016.5721.","journal-title":"Molecular Medicine Reports"},{"key":"9954_CR5","doi-asserted-by":"publisher","unstructured":"Wang, L., Wang, L., Cong, X., Liu, G., Zhou, J., Bai, B., Li, Y., Bai, W., Li, M., Ji, H., Zhu, D., Wu, M., & Liu, Y. (2013). Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and Efficacy (Vol. 22). https:\/\/doi.org\/10.1089\/scd.2013.0023.","DOI":"10.1089\/scd.2013.0023"},{"issue":"7","key":"9954_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/qjmed\/hcu033","volume":"107","author":"JJ El-Jawhari","year":"2014","unstructured":"El-Jawhari, J. J., El-Sherbiny, Y. M., Jones, E. A., & McGonagle, D. (2014). Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. Qjm, 107(7), 505\u2013514. https:\/\/doi.org\/10.1093\/qjmed\/hcu033.","journal-title":"Qjm"},{"key":"9954_CR7","doi-asserted-by":"publisher","unstructured":"Jaroughi, N., Azimian, V., Mardpour, S., Kakroodi, F. A., Bolurieh, T., & Hosseini, S. E. (2018). Intra-articular knee implantation of autologous bone marrow \u2013 derived involvement : Results of a randomized , triple-blind , placebo-controlled. Cytotherapy, (79). https:\/\/doi.org\/10.1016\/j.jcyt.2017.12.009.","DOI":"10.1016\/j.jcyt.2017.12.009"},{"issue":"5","key":"9954_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/stem.406","volume":"28","author":"GHW Tso","year":"2010","unstructured":"Tso, G. H. W., Law, H. K. W., Tu, W., Chan, G. C. F., & Lau, Y. L. (2010). Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells. Stem Cells, 28(5), 939\u2013954. https:\/\/doi.org\/10.1002\/stem.406.","journal-title":"Stem Cells"},{"key":"9954_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.intimp.2017.03.016","volume":"47","author":"R Baharlou","year":"2017","unstructured":"Baharlou, R., Ahmadi-Vasmehjani, A., Faraji, F., Atashzar, M. R., Khoubyari, M., Ahi, S., Erfanian, S., & Navabi, S. S. (2017). Human adipose tissue-derived mesenchymal stem cells in rheumatoid arthritis: Regulatory effects on peripheral blood mononuclear cells activation. International Immunopharmacology, 47, 59\u201369. https:\/\/doi.org\/10.1016\/j.intimp.2017.03.016.","journal-title":"International Immunopharmacology"},{"key":"9954_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0031","volume-title":"Intravenous infusion of umbilical cord blood- derived Mesenchymal stem cells in rheumatoid arthritis : A phase 1a clinical trial, 1\u20137","author":"D Rheumatology","year":"2018","unstructured":"Rheumatology, D. (2018). Intravenous infusion of umbilical cord blood- derived Mesenchymal stem cells in rheumatoid arthritis : A phase 1a clinical trial, 1\u20137. https:\/\/doi.org\/10.1002\/sctm.18-0031."},{"key":"9954_CR11","unstructured":"FDA, & CBER (2019). Expedited Programs for Regenerative Medicine Therapies for Serious Conditions; Guidance for Industry. Retrieved from http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm."},{"key":"9954_CR12","doi-asserted-by":"publisher","unstructured":"Ratajczak, M. Z., Marycz, K., Poniewierska-Baran, A., Fiedorowicz, K., Zbucka-Kretowska, M., & Moniuszko, M. (2014, September 1). Very small embryonic-like stem cells as a novel developmental concept and the hierarchy of the stem cell compartment. Advances in Medical Sciences. Medical University of Bialystok.\nhttps:\/\/doi.org\/10.1016\/j.advms.2014.08.001.","DOI":"10.1016\/j.advms.2014.08.001"},{"issue":"1","key":"9954_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13075-015-0634-1","volume":"17","author":"C De Bari","year":"2015","unstructured":"De Bari, C. (2015). Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys? Arthritis Research & Therapy, 17(1), 113. https:\/\/doi.org\/10.1186\/s13075-015-0634-1.","journal-title":"Arthritis Research & Therapy"},{"key":"9954_CR14","doi-asserted-by":"crossref","unstructured":"Ham, O., Lee, C. Y., Song, B., Lee, S., Kim, R., Park, J., Lee, J., Seo, H., Lee, C. Y., Chung, Y., Maeng, L., Lee, M. Y., Kim, J., Hwang, J., Woo, D. K., & Chang, W. (2014). Upregulation of miR-23b Enhances the Autologous Therapeutic Potential for Degenerative Arthritis by Targeting PRKACB in Synovial Fluid-Derived Mesenchymal Stem Cells from Patients., 37(6), 449\u2013456.","DOI":"10.14348\/molcells.2014.0023"},{"issue":"1","key":"9954_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/ard.2008.101881","volume":"69","author":"E Gonzalez-Rey","year":"2010","unstructured":"Gonzalez-Rey, E., Gonzalez, M. A., Varela, N., O\u2019Valle, F., Hernandez-Cortes, P., Rico, L., B\u00fcscher, D., & Delgado, M. (2010). Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(1), 241\u2013248. https:\/\/doi.org\/10.1136\/ard.2008.101881.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"9954_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia, J. M., Jover, J. A., Garc\u00eda-Vicu\u00f1a, R., Carre\u00f1o, L., Alonso, A., Marsal, S., Blanco, F., Mart\u00ednez-Taboada, V. M., Taylor, P., Mart\u00edn-Mart\u00edn, C., DelaRosa, O., Tagarro, I., & D\u00edaz-Gonz\u00e1lez, F. (2017). Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Annals of the Rheumatic Diseases, 76(1), 196\u2013202. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208918.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"9954_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/kem284","volume":"47","author":"ZH Zheng","year":"2008","unstructured":"Zheng, Z. H., Li, X. Y., Ding, J., Jia, J. F., & Zhu, P. (2008). Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology, 47(1), 22\u201330. https:\/\/doi.org\/10.1093\/rheumatology\/kem284.","journal-title":"Rheumatology"},{"issue":"2","key":"9954_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/jcmm.12972","volume":"21","author":"K Kornicka","year":"2017","unstructured":"Kornicka, K., Marycz, K., Mar\u0119dziak, M., Tomaszewski, K. A., & Nicpo\u0144, J. (2017). The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells. Journal of Cellular and Molecular Medicine, 21(2), 387\u2013401. https:\/\/doi.org\/10.1111\/jcmm.12972.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"9954_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1471-2474-13-249","volume":"13","author":"Q Wang","year":"2012","unstructured":"Wang, Q., Li, X., Luo, J., Zhang, L., Ma, L., Lv, Z., & Xue, L. (2012). The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system. BMC Musculoskeletal Disorders, 13(1), 249\u2013247. https:\/\/doi.org\/10.1186\/1471-2474-13-249.","journal-title":"BMC Musculoskeletal Disorders"},{"key":"9954_CR20","doi-asserted-by":"publisher","unstructured":"Cislo-Pakuluk, A., & Marycz, K. (2017). A promising tool in retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications. Stem Cell Reviews and Reports. Humana Press Inc. https:\/\/doi.org\/10.1007\/s12015-017-9750-4, .","DOI":"10.1007\/s12015-017-9750-4"},{"key":"9954_CR21","doi-asserted-by":"publisher","unstructured":"Kornicka, K., Houston, J., & Marycz, K. (2018). Dysfunction of Mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use. Stem Cell Reviews and Reports. Humana Press Inc. https:\/\/doi.org\/10.1007\/s12015-018-9809-x.","DOI":"10.1007\/s12015-018-9809-x"},{"issue":"1","key":"9954_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12015-014-9545-9","volume":"11","author":"J Tay","year":"2014","unstructured":"Tay, J., Allan, D. S., Le, Y., Fergusson, D., Akyurekli, C., & Richardson, R. B. (2014). A systematic review of preclinical studies on the therapeutic potential of Mesenchymal stromal cell-derived microvesicles. Stem Cell Reviews and Reports, 11(1), 150\u2013160. https:\/\/doi.org\/10.1007\/s12015-014-9545-9.","journal-title":"Stem Cell Reviews and Reports"},{"key":"9954_CR23","doi-asserted-by":"crossref","unstructured":"Kim, K., Kim, H. J., Kim, B., Kwon, Y., Kim, H., & Kim, Y. (2018). Epigenetic modification of mesenchymal stromal cells enhances their suppressive effects on the Th17 responses of cells from rheumatoid arthritis patients, 1\u201310.","DOI":"10.1186\/s13287-018-0948-4"},{"key":"9954_CR24","doi-asserted-by":"crossref","unstructured":"Kastrinaki, M., & Papadaki, H. A. (2009). Mesenchymal stromal cells in rheumatoid arthritis : Biological proper- ties and clinical applications, 61\u201369.","DOI":"10.2174\/157488809787169084"},{"issue":"2","key":"9954_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/BOR.0000000000000370","volume":"29","author":"S Ansboro","year":"2017","unstructured":"Ansboro, S., Roelofs, A. J., & De Bari, C. (2017). Mesenchymal stem cells for the management of rheumatoid arthritis. Current Opinion in Rheumatology, 29(2), 201\u2013207. https:\/\/doi.org\/10.1097\/BOR.0000000000000370.","journal-title":"Current Opinion in Rheumatology"},{"issue":"7","key":"9954_CR26","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group, T. P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Medicine"},{"key":"9954_CR27","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C., Savovi\u0107, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., et al. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed.), 366, l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ (Clinical research ed.)"},{"issue":"3","key":"9954_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000051263","volume":"12","author":"M Oremus","year":"2001","unstructured":"Oremus, M., Wolfson, C., Perrault, A., Demers, L., Momoli, F., & Moride, Y. (2001). Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer\u2019s disease drug trials. Dementia and Geriatric Cognitive Disorders, 12(3), 232\u2013236. https:\/\/doi.org\/10.1159\/000051263.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"4","key":"9954_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcyt.2017.12.009","volume":"20","author":"S Shadmanfar","year":"2018","unstructured":"Shadmanfar, S., Labibzadeh, N., Emadedin, M., Jaroughi, N., Azimian, V., Mardpour, S., Kakroodi, F. A., Bolurieh, T., Hosseini, S. E., Chehrazi, M., Niknejadi, M., Baharvand, H., Gharibdoost, F., & Aghdami, N. (2018). Intra-articular knee implantation of autologous bone marrow\u2013derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy, 20(4), 499\u2013506. https:\/\/doi.org\/10.1016\/j.jcyt.2017.12.009.","journal-title":"Cytotherapy"},{"issue":"4","key":"9954_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.berh.2010.01.008","volume":"24","author":"A Tyndall","year":"2010","unstructured":"Tyndall, A., & Van Laar, J. M. (2010). Stem cells in the treatment of inflammatory arthritis. Best Practice and Research: Clinical Rheumatology, 24(4), 565\u2013574. https:\/\/doi.org\/10.1016\/j.berh.2010.01.008.","journal-title":"Best Practice and Research: Clinical Rheumatology"},{"issue":"3","key":"9954_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/14728222.2013.746954","volume":"17","author":"RJ MacFarlane","year":"2013","unstructured":"MacFarlane, R. J., Graham, S. M., Davies, P. S., Korres, N., Tsouchnica, H., Heliotis, M., Mantalaris, A., & Tsiridis, E. (2013). Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: Potential for treatment. Expert Opinion on Therapeutic Targets, 17(3), 243\u2013254. https:\/\/doi.org\/10.1517\/14728222.2013.746954.","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"1","key":"9954_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","volume":"31","author":"J Liang","year":"2012","unstructured":"Liang, J., Li, X., Zhang, H., Wang, D., Feng, X., Wang, H., Hua, B., Liu, B., & Sun, L. (2012). Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clinical Rheumatology, 31(1), 157\u2013161. https:\/\/doi.org\/10.1007\/s10067-011-1816-0.","journal-title":"Clinical Rheumatology"},{"issue":"10","key":"9954_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/kep162","volume":"48","author":"C Bouffi","year":"2009","unstructured":"Bouffi, C., Djouad, F., Mathieu, M., Noel, D., & Jorgensen, C. (2009). Multipotent mesenchymal stromal cells and rheumatoid arthritis: Risk or benefit? Rheumatology, 48(10), 1185\u20131189. https:\/\/doi.org\/10.1093\/rheumatology\/kep162.","journal-title":"Rheumatology"},{"issue":"6","key":"9954_CR34","doi-asserted-by":"publisher","first-page":"R210","DOI":"10.1186\/ar3187","volume":"12","author":"Y Liu","year":"2010","unstructured":"Liu, Y., Mu, R., Wang, S., Long, L., Liu, X., Li, R., et al. (2010). Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Research & Therapy, 12(6), R210. https:\/\/doi.org\/10.1186\/ar3187.","journal-title":"Arthritis Research & Therapy"},{"issue":"2s","key":"9954_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/https","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt, G., Jennifer Eriksson, G. P., & J. B. (2017). The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms. Multiple Sclerosis Journal, 23(2s), 153\u2013156. https:\/\/doi.org\/10.1177\/https.","journal-title":"Multiple Sclerosis Journal"},{"key":"9954_CR36","doi-asserted-by":"publisher","unstructured":"Perdisa, F., Gosty\u0144ska, N., Roffi, A., Filardo, G., Marcacci, M., & Kon, E. (2015). Adipose-derived Mesenchymal stem cells for the treatment of articular cartilage: A systematic review on preclinical and clinical evidence. Stem Cells International, 2015. https:\/\/doi.org\/10.1155\/2015\/597652.","DOI":"10.1155\/2015\/597652"},{"issue":"12","key":"9954_CR37","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1111\/jcmm.12378","volume":"18","author":"M Mazor","year":"2014","unstructured":"Mazor, M., Lespessailles, E., Coursier, R., Daniellou, R., Best, T. M., & Toumi, H. (2014). Mesenchymal stem-cell potential in cartilage repair: An update. Journal of Cellular and Molecular Medicine, 18(12), 2340\u20132350. https:\/\/doi.org\/10.1111\/jcmm.12378.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"9954_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/scrt55","volume":"2","author":"M Maumus","year":"2011","unstructured":"Maumus, M., Gu\u00e9rit, D., Toupet, K., Jorgensen, C., & No\u00ebl, D. (2011). Mesenchymal stem cell-based therapies in regenerative medicine: Applications in rheumatology. Stem Cell Research & Therapy, 2(2), 14. https:\/\/doi.org\/10.1186\/scrt55.","journal-title":"Stem Cell Research & Therapy"},{"issue":"7","key":"9954_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","volume":"5","author":"F Djouad","year":"2009","unstructured":"Djouad, F., Bouffi, C., Ghannam, S., No\u00ebl, D., & Jorgensen, C. (2009). Mesenchymal stem cells: Innovative therapeutic tools for rheumatic diseases. Nature Reviews Rheumatology, 5(7), 392\u2013399. https:\/\/doi.org\/10.1038\/nrrheum.2009.104.","journal-title":"Nature Reviews Rheumatology"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-09954-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12015-020-09954-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-09954-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T01:08:49Z","timestamp":1610672929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12015-020-09954-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["9954"],"URL":"https:\/\/doi.org\/10.1007\/s12015-020-09954-z","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,16]]},"assertion":[{"value":"16 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}